SE0402976D0 - A medical product - Google Patents

A medical product

Info

Publication number
SE0402976D0
SE0402976D0 SE0402976A SE0402976A SE0402976D0 SE 0402976 D0 SE0402976 D0 SE 0402976D0 SE 0402976 A SE0402976 A SE 0402976A SE 0402976 A SE0402976 A SE 0402976A SE 0402976 D0 SE0402976 D0 SE 0402976D0
Authority
SE
Sweden
Prior art keywords
medical product
container
dose
optionally
inhalation
Prior art date
Application number
SE0402976A
Other languages
English (en)
Other versions
SE0402976L (sv
Inventor
Thomas Nilsson
Sven Calander
Alf Niemi
Claes Friberg
Lars Kax
Mattias Myrman
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0402976A priority Critical patent/SE0402976L/sv
Publication of SE0402976D0 publication Critical patent/SE0402976D0/sv
Priority to US11/049,696 priority patent/US20060120969A1/en
Priority to ZA200705376A priority patent/ZA200705376B/xx
Priority to JP2007544302A priority patent/JP2008521893A/ja
Priority to CNA2005800476483A priority patent/CN101111226A/zh
Priority to KR1020077015300A priority patent/KR20070095927A/ko
Priority to CA002589118A priority patent/CA2589118A1/en
Priority to BRPI0518600-5A priority patent/BRPI0518600A2/pt
Priority to RU2007124795/15A priority patent/RU2007124795A/ru
Priority to PCT/SE2005/001648 priority patent/WO2006059939A1/en
Priority to MX2007006533A priority patent/MX2007006533A/es
Priority to AU2005310367A priority patent/AU2005310367A1/en
Priority to EP05801482A priority patent/EP1827381A1/en
Priority to US11/272,859 priority patent/US20060239933A1/en
Publication of SE0402976L publication Critical patent/SE0402976L/sv
Priority to IL183623A priority patent/IL183623A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
SE0402976A 2004-12-03 2004-12-03 Medicinsk produkt SE0402976L (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt
US11/049,696 US20060120969A1 (en) 2004-12-03 2005-02-04 Medical product for inhalation containing glucagon-like peptide-1 (GLP-1)
EP05801482A EP1827381A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
CA002589118A CA2589118A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
PCT/SE2005/001648 WO2006059939A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
CNA2005800476483A CN101111226A (zh) 2004-12-03 2005-11-02 包含预期用于肺吸入的胰高血糖素样肽药物的医学产品
KR1020077015300A KR20070095927A (ko) 2004-12-03 2005-11-02 폐 흡입을 위한 글루카곤-형 펩타이드 약제를 포함하는의약품
ZA200705376A ZA200705376B (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
BRPI0518600-5A BRPI0518600A2 (pt) 2004-12-03 2005-11-02 produto mÉdico compreendendo um medicamento de peptÍdeo tipo glucagon, idealizado para inalaÇço pulmonar
RU2007124795/15A RU2007124795A (ru) 2004-12-03 2005-11-02 Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции
JP2007544302A JP2008521893A (ja) 2004-12-03 2005-11-02 肺吸入用のグルカゴン様ペプチド薬物を含む医療品
MX2007006533A MX2007006533A (es) 2004-12-03 2005-11-02 Un producto medico que comprende un medicamento peptidico tipo glucagon pretendido para inhalacion pulmonar.
AU2005310367A AU2005310367A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
US11/272,859 US20060239933A1 (en) 2004-12-03 2005-11-15 Medical product
IL183623A IL183623A0 (en) 2004-12-03 2007-06-03 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt

Publications (2)

Publication Number Publication Date
SE0402976D0 true SE0402976D0 (sv) 2004-12-03
SE0402976L SE0402976L (sv) 2006-06-04

Family

ID=33550603

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt

Country Status (9)

Country Link
US (2) US20060120969A1 (sv)
JP (1) JP2008521893A (sv)
CN (1) CN101111226A (sv)
BR (1) BRPI0518600A2 (sv)
IL (1) IL183623A0 (sv)
MX (1) MX2007006533A (sv)
RU (1) RU2007124795A (sv)
SE (1) SE0402976L (sv)
ZA (1) ZA200705376B (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196430B1 (en) 1999-06-29 2012-02-15 MannKind Corporation Purification and stabilization of peptide and protein pharmaceutical agents
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US8921311B2 (en) 2003-08-01 2014-12-30 Mannkind Corporation Method for treating hyperglycemia
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
PL1791542T3 (pl) 2004-08-23 2015-11-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
EP2497484A3 (en) 2006-02-22 2012-11-07 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
MX2010004508A (es) * 2007-10-24 2010-07-02 Mannkind Corp Suministro de agentes activos.
CA2703338A1 (en) * 2007-10-24 2009-04-30 Mannkind Corporation Method of preventing adverse effects by glp-1
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (da) 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
EP3412300A1 (en) 2008-06-27 2018-12-12 Duke University Therapeutic agents comprising elastin-like peptides
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2379100T3 (en) 2009-01-08 2014-12-01 Mannkind Corp Treatment of hyperglycemia with GLP-1
EP2400950B1 (en) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8734845B2 (en) * 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5801997B2 (ja) * 2009-07-07 2015-10-28 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器
WO2011017554A2 (en) 2009-08-07 2011-02-10 Mannkind Corporation Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
US9707176B2 (en) 2009-11-13 2017-07-18 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
US20110118178A1 (en) * 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2552414A4 (en) * 2010-03-31 2014-05-14 Glenmark Pharmaceuticals Ltd PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3402558B1 (en) 2016-01-11 2023-11-29 Syqe Medical Ltd. Personal vaporizing device
WO2023224577A1 (en) * 2022-05-18 2023-11-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising micronized human insulin
CN115192554A (zh) * 2022-08-08 2022-10-18 浙江仙琚萃泽医药科技有限公司 无抛射剂的含肽吸入溶液剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409496D0 (en) * 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
US6720407B1 (en) * 1998-08-28 2004-04-13 Eli Lilly And Company Method for administering insulinotropic peptides
FI108518B (sv) * 1999-04-23 2002-02-15 Orion Yhtymae Oyj Pulverinhalator för kombinationsmedicin
US6528486B1 (en) * 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
US20010012829A1 (en) * 2000-01-11 2001-08-09 Keith Anderson Transepithelial delivery GLP-1 derivatives
US7186683B2 (en) * 2000-09-18 2007-03-06 Sanos Bioscience A/S Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
SE0101233L (sv) * 2001-04-05 2002-10-01 Microdrug Ag Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt

Also Published As

Publication number Publication date
CN101111226A (zh) 2008-01-23
SE0402976L (sv) 2006-06-04
RU2007124795A (ru) 2009-01-10
US20060120969A1 (en) 2006-06-08
BRPI0518600A2 (pt) 2008-11-25
MX2007006533A (es) 2007-08-02
JP2008521893A (ja) 2008-06-26
US20060239933A1 (en) 2006-10-26
IL183623A0 (en) 2007-09-20
ZA200705376B (en) 2008-12-31

Similar Documents

Publication Publication Date Title
SE0402976D0 (sv) A medical product
BRPI0417155A (pt) produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade
MY187036A (en) Inhalation device and method
MX2010008234A (es) Nueva dosificacion y formulacion.
WO2012041938A3 (en) Inhaler
CY1110636T1 (el) Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
MX2010008235A (es) Nueva dosificacion y formulacion.
DE602005016410D1 (de) Verbessertes medizinprodukt
SE0402345D0 (sv) A metered medication dose
Rave et al. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles 1
JP2004533438A5 (sv)
AR094287A1 (es) Metodos y composiciones para administracion de oxibutinina

Legal Events

Date Code Title Description
NAV Patent application has lapsed
NAV Patent application has lapsed